Types
- Obstructive sleep apnea (OSA) — the throat repeatedly collapses during sleep, cutting off airflow. An estimated 936 million adults aged 30 to 69 have it, 425 million of them with moderate-to-severe disease1.
- Central sleep apnea — the brain intermittently stops signaling the body to breathe; linked to heart failure, opioids, and high altitude.
- Chronic insomnia — trouble falling or staying asleep at least three nights a week for three months, with daytime effects4.
- Other sleep disorders include restless legs syndrome, narcolepsy, and circadian rhythm disorders.
Prevention
- Keeping a healthy weight is the main way to lower the risk of OSA; weight loss reduces its severity5.
- Consistent sleep habits help keep short-term sleep trouble from becoming chronic insomnia.
Risk factors
- OSA: excess weight, male sex, older age, a thick neck, a narrow airway or large tonsils, alcohol and sedatives, smoking1,2
- Insomnia: stress, anxiety and depression, chronic pain, irregular schedules or shift work, caffeine, and alcohol4
Diagnostics
- OSA is diagnosed with an in-lab sleep study (polysomnography) or, for uncomplicated adults likely to have moderate-to-severe OSA, a home sleep apnea test2.
- Questionnaires such as STOP-BANG flag who needs testing, but can't diagnose OSA on their own2.
- Severity is measured by the apnea-hypopnea index (AHI) — breathing pauses per hour of sleep: 5–14 mild, 15–29 moderate, 30 or more severe.
- Insomnia is diagnosed from your history, often with a sleep diary. A sleep study is only needed if another sleep disorder is suspected4.
Treatments
- OSA — positive airway pressure (CPAP) is the standard treatment for adults with daytime sleepiness, poor sleep-related quality of life, or high blood pressure3.
- OSA — weight loss. In people with obesity and moderate-to-severe OSA, tirzepatide cut breathing pauses by more than half5.
- OSA — alternatives for people who can't use CPAP: oral appliances, sleeping on your side, surgery, or a hypoglossal nerve stimulator.
- Insomnia — cognitive behavioral therapy for insomnia (CBT-I) is the recommended first treatment4.
- Insomnia — medication is a short-term, shared decision when CBT-I alone isn't enough4.
Molecular Biomarkers
- No blood test diagnoses sleep apnea or insomnia. Diagnosis rests on sleep testing and history2,4.
- Sleep studies measure blood oxygen levels and how often they drop overnight (the oxygen desaturation index)2.
Genes
- No genetic test is used in care. OSA runs in families largely through inherited traits such as jaw and airway shape and body weight.
- Insomnia is moderately heritable, spread across many genetic variants that each have a small effect.
Lifestyle
- Keep the same sleep and wake times every day, including weekends4.
- Get out of bed if you can't sleep after about 20 minutes, and return when sleepy.
- Avoid alcohol and sedatives near bedtime; they relax the airway and worsen apnea.
- Sleep on your side if apnea is worse on your back.
- Limit caffeine after midday and screens in bed.
Nutrition
- Losing weight through diet reduces the severity of OSA5.
- Avoid heavy meals and alcohol within 2 to 3 hours of bedtime.
- Melatonin has a small effect on how fast you fall asleep and is most useful for jet lag and shift work.
Medical Interventions
- CPAP and other positive airway pressure devices3
- Custom oral appliances that move the lower jaw forward
- Upper-airway surgery, or an implanted hypoglossal nerve stimulator
- CBT-I, in person or through a digital program4
Pharmaceutical Drugs
- Tirzepatide — approved by the FDA for moderate-to-severe OSA in adults with obesity5
- For insomnia, short-term: orexin receptor antagonists (suvorexant, lemborexant, daridorexant), zolpidem, eszopiclone, and low-dose doxepin, after CBT-I4
- Avoid relying on over-the-counter antihistamine sleep aids; they cause next-day grogginess and aren't recommended for chronic insomnia.
Sources
- Benjafield AV, Ayas NT, Eastwood PR, et al. Estimation of the global prevalence and burden of obstructive sleep apnoea: a literature-based analysis. Lancet Respir Med. 2019;7(8):687-698. doi:10.1016/S2213-2600(19)30198-5
- Kapur VK, Auckley DH, Chowdhuri S, et al. Clinical practice guideline for diagnostic testing for adult obstructive sleep apnea: an American Academy of Sleep Medicine clinical practice guideline. J Clin Sleep Med. 2017;13(3):479-504. doi:10.5664/jcsm.6506
- Patil SP, Ayappa IA, Caples SM, et al. Treatment of adult obstructive sleep apnea with positive airway pressure: an American Academy of Sleep Medicine clinical practice guideline. J Clin Sleep Med. 2019;15(2):335-343. doi:10.5664/jcsm.7640
- Qaseem A, Kansagara D, Forciea MA, et al. Management of chronic insomnia disorder in adults: a clinical practice guideline from the American College of Physicians. Ann Intern Med. 2016;165(2):125-133. doi:10.7326/M15-2175
- Malhotra A, Grunstein RR, Fietze I, et al. Tirzepatide for the treatment of obstructive sleep apnea and obesity. N Engl J Med. 2024;391(13):1193-1205. doi:10.1056/NEJMoa2404881
This page summarizes published research for education. It isn't medical advice and doesn't replace care from a clinician who knows your history. Never start, stop, or change a medication without talking to your prescriber.